Physician profile
Eduardo S Ramirez
NPI 1588652911
$6,923.59
in general payments reported to CMS, 2019-2025
10 companies · $651 in 2025
The $651 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $485 · 2021: $1,015 · 2022: $1,365 · 2023: $2,405 · 2024: $636 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,529 · Travel and Lodging: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,528.56 |
| Travel and Lodging | $1,163.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,853.27 | 2019-2024 | Supera, Perclose Proglide, Jeti Peripheral Catheter |
| Medtronic, INC. | $2,652.86 | 2021-2025 | Corevalve Evolut R, Venaseal, Micra |
| Janssen Pharmaceuticals, INC | $284.38 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $272.28 | 2020 | |
| Cardiovascular Systems INC. | $237.01 | 2021-2023 | Diamondback Peripheral |
| Boston Scientific Corporation | $171.51 | 2021-2025 | Watchman Flx |
| Inari Medical, INC. | $169.14 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Esperion Therapeutics, INC. | $124.36 | 2022 | |
| Edwards Lifesciences Corporation | $89.62 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $69.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.